Starfire Investment Advisers, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Starfire Investment Advisers, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$875,000
+11.9%
16,5430.0%0.42%
-2.8%
Q1 2020$782,000
-60.9%
16,543
-50.0%
0.43%
+12.6%
Q4 2019$1,998,000
+101.6%
33,086
+100.0%
0.38%
-5.9%
Q3 2019$991,000
-6.8%
16,5430.0%0.41%
-14.5%
Q2 2019$1,063,000
-20.8%
16,5430.0%0.48%
-22.9%
Q1 2019$1,342,000
-24.9%
16,543
-50.0%
0.62%
+27.8%
Q4 2018$1,788,000
+8.4%
33,086
+3.4%
0.48%
+17.6%
Q3 2018$1,650,000
+19.7%
32,000
-3.3%
0.41%
+17.5%
Q2 2018$1,378,000
+89.0%
33,086
+100.0%
0.35%
-8.2%
Q1 2018$729,000
-13.0%
16,5430.0%0.38%
-25.2%
Q3 2017$838,000
-0.4%
16,5430.0%0.51%
+3.3%
Q2 2017$841,000
-99.9%
16,5430.0%0.49%
+40.2%
Q1 2017$650,967,000
-17.7%
16,5430.0%0.35%
-22.3%
Q4 2016$791,251,000
-34.7%
16,543
-50.0%
0.45%
+26.3%
Q3 2016$1,212,270,000
+57.3%
33,0860.0%0.36%
+35.1%
Q2 2016$770,572,000
-42.5%
33,0860.0%0.26%
-39.8%
Q1 2016$1,339,982,000
-34.6%
33,0860.0%0.44%
-37.5%
Q4 2015$2,049,014,00033,0860.70%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders